Optiver Holding
RGNX icon

Optiver Holding’s Regenxbio RGNX Stock Holding History

Optiver Holding’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.3K Sell
1,110
-112
-9% -$929 ﹤0.01% 1669
2026
Q1 		$10.2K Sell
1,222
-324
-21% -$3.4K ﹤0.01% 1213
2025
Q4 		$22.3K Buy
1,546
+1,100
+247% +$13.7K ﹤0.01% 1012
2025
Q3 		$4.3K Buy
+446
New +$3.94K ﹤0.01% 1869

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Optiver Holding's RGNX Position: Q2 2026 in Review

Optiver Holding reduced its Regenxbio (RGNX) stake by 9.2% in Q2 2026, selling an estimated $929 and leaving 1,110 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1669.

Optiver Holding first reported a position in RGNX in Q3 2025 and has held it in 4 quarters since. The position peaked at $22.3K in Q4 2025. 164 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Optiver Holding held 1,110 shares of Regenxbio worth $13.3K as of Q2 2026.
  • Optiver Holding sold 112 Regenxbio shares in Q2 2026, an estimated $929.
  • Regenxbio made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1669 holding.
  • Optiver Holding first reported a position in Regenxbio in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Regenxbio position peaked at $22.3K in Q4 2025.
  • 164 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.